4//SEC Filing
Holbrook Kerr 4
Accession 0001606498-25-000032
CIK 0001606498other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 2:24 PM ET
Size
8.6 KB
Accession
0001606498-25-000032
Insider Transaction Report
Form 4
Holbrook Kerr
SVP, Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2025-03-04+5,145→ 92,393 total - Tax Payment
Common Stock
2025-03-04$15.13/sh−1,803$27,279→ 90,590 total - Tax Payment
Common Stock
2025-03-04$15.13/sh−1,543$23,346→ 89,047 total
Footnotes (4)
- [F1]Represents performance-based restricted share units (PRSUs) which: (i) were awarded to the Reporting Person on March 4, 2022 and (ii) vested on March 4, 2025. Each PRSU is the economic eqiuvalent of one share of Common Stock.
- [F2]Total beneficially owned includes 117 shares acquired on December 31, 2024 and 1,000 shares acquired on June 30, 2024 under the Issuer's Employee Stock Purchase Plan.
- [F3]Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 5,145 PRSUs which vested on March 4, 2025.
- [F4]Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 4,403 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on March 4, 2022 and (ii) vested on March 4, 2025. Each TRSU is the economic equivalent of one share of Common Stock.
Documents
Issuer
AVANOS MEDICAL, INC.
CIK 0001606498
Entity typeother
Related Parties
1- filerCIK 0001861246
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 2:24 PM ET
- Size
- 8.6 KB